EVCM Insider Notice: 10,000 Shares for Sale via Morgan Stanley
Rhea-AI Filing Summary
EverCommerce Inc. (EVCM) filed a Form 144 notifying the proposed sale of 10,000 common shares through Morgan Stanley Smith Barney LLC. The filing lists an aggregate market value of $106,200 and reports 181,278,754 shares outstanding, with an approximate sale date of 08/14/2025. The shares are to be sold on NASDAQ.
The 10,000 shares match restricted stock grants acquired from the issuer on 05/22/2024 (1,963 shares), 05/14/2025 (1,722 shares) and 06/05/2025 (6,315 shares). No securities were reported sold in the past three months. The filer represents they are not aware of undisclosed material adverse information.
Positive
- None.
Negative
- None.
Insights
TL;DR: Insider plans to sell 10,000 shares (aggregate value $106,200) — a small fraction of outstanding stock, so limited market impact.
The Form 144 discloses a proposed sale executed through Morgan Stanley Smith Barney LLC with an approximate trade date of 08/14/2025. The 10,000 shares represent roughly 0.0055% of the 181,278,754 shares outstanding, indicating this transaction is unlikely to move the market or materially change supply-demand dynamics. The shares were issued as restricted stock across three acquisition dates, suggesting the sale is of recently vested compensation rather than liquidation of long-held positions. No recent sales were reported in the prior three months, and the filer attests to no undisclosed material adverse information.
TL;DR: Filing demonstrates compliance with Rule 144 disclosure requirements; transaction appears routine and non-material to investors.
The notice provides required broker routing and provenance of the shares (all restricted stock from the issuer), satisfying disclosure obligations under Rule 144. The signature attestation about material adverse information and reference to 10b5-1 plans (if applicable) align with standard insider-sale governance practices. Given the small size relative to outstanding shares and absence of other insider sales in the past three months, this Form 144 is a routine governance-level disclosure rather than an indicator of broader corporate control or liquidity events.